AU2021311713A1 - Methods for nomination of nuclease on-/off-target editing locations, designated "CTL-seq" (CRISPR tag linear-seq) - Google Patents

Methods for nomination of nuclease on-/off-target editing locations, designated "CTL-seq" (CRISPR tag linear-seq) Download PDF

Info

Publication number
AU2021311713A1
AU2021311713A1 AU2021311713A AU2021311713A AU2021311713A1 AU 2021311713 A1 AU2021311713 A1 AU 2021311713A1 AU 2021311713 A AU2021311713 A AU 2021311713A AU 2021311713 A AU2021311713 A AU 2021311713A AU 2021311713 A1 AU2021311713 A1 AU 2021311713A1
Authority
AU
Australia
Prior art keywords
sequences
tag
primers
sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021311713A
Other languages
English (en)
Inventor
Ellen BLACK
Keith GUNDERSON
Kyle KINNEY
Matthew Mcneill
Garrett Rettig
Chris SAILOR
Yongming Sun
Rolf TURK
Yu Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Integrated DNA Technologies Inc
Original Assignee
Integrated DNA Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integrated DNA Technologies Inc filed Critical Integrated DNA Technologies Inc
Publication of AU2021311713A1 publication Critical patent/AU2021311713A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111General methods applicable to biologically active non-coding nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2021311713A 2020-07-23 2021-07-22 Methods for nomination of nuclease on-/off-target editing locations, designated "CTL-seq" (CRISPR tag linear-seq) Pending AU2021311713A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063055460P 2020-07-23 2020-07-23
US63/055,460 2020-07-23
PCT/US2021/042733 WO2022020567A2 (en) 2020-07-23 2021-07-22 Methods for nomination of nuclease on-/off-target editing locations, designated "ctl-seq" (crispr tag linear-seq)

Publications (1)

Publication Number Publication Date
AU2021311713A1 true AU2021311713A1 (en) 2023-03-09

Family

ID=77338877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021311713A Pending AU2021311713A1 (en) 2020-07-23 2021-07-22 Methods for nomination of nuclease on-/off-target editing locations, designated "CTL-seq" (CRISPR tag linear-seq)

Country Status (8)

Country Link
US (2) US20220025365A1 (https=)
EP (1) EP4185708A2 (https=)
JP (2) JP2023535407A (https=)
KR (1) KR20230040370A (https=)
CN (1) CN116194593A (https=)
AU (1) AU2021311713A1 (https=)
CA (1) CA3185571A1 (https=)
WO (1) WO2022020567A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202013141D0 (en) 2020-08-21 2020-10-07 Univ College Cardiff Consultants Ltd A screening method for the detection of DNA damage
WO2025151661A1 (en) * 2024-01-10 2025-07-17 Sequre Dx, Inc. Methods for single-ended oligonucleotide enrichment and sequencing
WO2026039499A1 (en) 2024-08-14 2026-02-19 Integrated Dna Technologies, Inc. Adaptered-tag blocking oligonucleotides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9809904B2 (en) * 2011-04-21 2017-11-07 University Of Washington Through Its Center For Commercialization Methods for retrieval of sequence-verified DNA constructs
CN111254500B (zh) * 2012-12-10 2024-01-23 分析生物科学有限公司 靶向基因组分析的方法
CA2906365A1 (en) * 2013-03-15 2014-09-18 Integrated Dna Technologies, Inc. Rnase h-based assays utilizing modified rna monomers
CN106604994B (zh) * 2014-06-23 2021-12-14 通用医疗公司 通过测序评估的DSBs的全基因组无偏鉴定(GUIDE-Seq)
WO2016030899A1 (en) * 2014-08-28 2016-03-03 Yeda Research And Development Co. Ltd. Methods of treating amyotrophic lateral scleroses
EP3221813A4 (en) * 2014-11-20 2018-04-18 Children's Medical Center Corporation Methods relating to the detection of recurrent and non-specific double strand breaks in the genome
IL269431B2 (en) * 2017-03-23 2025-05-01 Univ Washington Methods for targeted nucleic acid sequence enrichment with applications to error corrected nucleic acid sequencing
CN111868260B (zh) * 2017-08-07 2025-02-21 约翰斯霍普金斯大学 用于评估和治疗癌症的方法和材料
WO2019110067A1 (en) * 2017-12-07 2019-06-13 Aarhus Universitet Hybrid nanoparticle

Also Published As

Publication number Publication date
WO2022020567A3 (en) 2022-03-10
JP2026048971A (ja) 2026-03-17
JP2023535407A (ja) 2023-08-17
CA3185571A1 (en) 2022-01-27
CN116194593A (zh) 2023-05-30
US20220025365A1 (en) 2022-01-27
KR20230040370A (ko) 2023-03-22
EP4185708A2 (en) 2023-05-31
US20250257352A1 (en) 2025-08-14
WO2022020567A2 (en) 2022-01-27

Similar Documents

Publication Publication Date Title
EP3565907B1 (en) Methods of assessing nuclease cleavage
EP3555305B1 (en) Method for increasing throughput of single molecule sequencing by concatenating short dna fragments
JP2022137097A (ja) シークエンシングによって評価されるゲノムワイドでバイアスのないDSBの同定(GUIDE-Seq)
US20250257352A1 (en) METHODS FOR NOMINATION OF NUCLEASE ON-/OFF-TARGET EDITING LOCATIONS, DESIGNATED "CTL-seq" (CRISPR Tag Linear-seq)
US20230056763A1 (en) Methods of targeted sequencing
JP7292258B2 (ja) 縦列反復配列を有するドナーdna修復鋳型を使用する部位特異的なdna改変
JP2010535513A (ja) 高スループット亜硫酸水素dnaシークエンシングのための方法および組成物ならびに有用性
JP6924779B2 (ja) トランスポザーゼランダムプライミング法によるdna試料の調製
AU2019282812B2 (en) Compositions and methods for making guide nucleic acids
US20130123117A1 (en) Capture probe and assay for analysis of fragmented nucleic acids
WO2021081358A1 (en) Modified double-stranded donor templates
US20170175182A1 (en) Transposase-mediated barcoding of fragmented dna
US20230122979A1 (en) Methods of sample normalization
WO2025024703A1 (en) Dual-tagmentation single-cell dnaseq
US11692219B2 (en) Construction of next generation sequencing (NGS) libraries using competitive strand displacement
WO2021058145A1 (en) Phage t7 promoters for boosting in vitro transcription
US20260085308A1 (en) Methods for generating cdna library from rna
EP3851542A1 (en) Depletion of abundant uninformative sequences
WO2025083338A1 (en) An in vitro method for fragmenting polynucleotides for next generation sequencing
WO2023107899A2 (en) A method of capturing crispr endonuclease cleavage products
CN121428063A (zh) 一种利用转座酶构建测序文库的方法